(Q46168302)

20 December 2017

title

Adjuvant gemcitabine plus docetaxel for completely resected stages I-IV high grade uterine leiomyosarcoma: Results of a prospective study (English)

1 reference

20 December 2017

1 reference

1 reference

3

1 reference

20 December 2017

Jason Konner

7

1 reference

20 December 2017

Nadeem R. Abu-Rustum

5

object named as

Nadeem Abu-Rustum

1 reference

20 December 2017

Carol Aghajanian

10

object named as

Carol A Aghajanian

1 reference

20 December 2017

author name string

Martee L Hensley

1

1 reference

20 December 2017

Nicole Ishill

2

1 reference

20 December 2017

Joseph Larkin

4

1 reference

20 December 2017

Paul Sabbatini

6

1 reference

20 December 2017

William Tew

8

1 reference

20 December 2017

David Spriggs

9

1 reference

20 December 2017

language of work or name

English

0 references

publication date

9 January 2009

1 reference

20 December 2017

published in

Gynecologic Oncology

1 reference

20 December 2017

volume

112

1 reference

20 December 2017

issue

3

1 reference

20 December 2017

page(s)

563-567

1 reference

20 December 2017

Prognostic factors in early-stage uterine sarcoma. A Gynecologic Oncology Group study

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.11.027

The Prognostic Significance of ‘Stage, Tumor Size, Cellular Atypia and DNA Ploidy in Uterine Leiomyosarcoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.11.027

Endometrial Stromal Sarcoma: Analysis of Treatment Failures and Survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.11.027

The treatment of uterine leiomyosarcoma. Results from a 10-year experience (1990-1999) at the Massachusetts General Hospital

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.11.027

Leiomyosarcoma of the uterus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.11.027

Analysis of clinicopathologic prognostic factors for 157 uterine sarcomas and evaluation of a grading score validated for soft tissue sarcoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.11.027

Phase III randomised study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages I and II: an European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group Study (protocol 55874).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.11.027

A randomized clinical trial of adjuvant adriamycin in uterine sarcomas: a Gynecologic Oncology Group Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.11.027

Gemcitabine and docetaxel in patients with unresectable leiomyosarcoma: results of a phase II trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.11.027

Fixed-dose rate gemcitabine plus docetaxel as second-line therapy for metastatic uterine leiomyosarcoma: a Gynecologic Oncology Group phase II study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.11.027

Safety and efficacy of adjuvant single-agent ifosfamide in uterine sarcoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.11.027

Uterine sarcomas: the Curie Institut experience. Prognosis factors and adjuvant treatments

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.11.027

Adjuvant chemotherapy for adult soft tissue sarcoma: Is there a standard of care?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.11.027

Adjuvant chemotherapy with cisplatin, ifosfamide, and doxorubicin followed by radiotherapy in localized uterine sarcomas: results of a case-control study with radiotherapy alone.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.11.027

Efficacy of adjuvant CYVADIC chemotherapy in early-stage uterine sarcomas: results of long-term follow-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.11.027

10.1016/J.YGYNO.2008.11.027

7 January 2021

Identifiers

DOI

1 reference

20 December 2017

1 reference

20 December 2017